Wockhardt, one of the leading pharmaceutical and biotechnology company, today reported a fall of 93.83% in quarterly net profit, due to sharp fall in revenues and margins. 

Consolidated net profit was at Rs 199.5 million for the quarter ended June 30, 2014 as compared to Rs 3,233.1 million in the same period last year.

Total income has decreased by 27.03% to Rs 9.91 billion for the quarter ended June 30, 2014 from Rs 13.58 billion in the year ago period.

Operating margins fell sharply during the quarter to 2.45% from 28.62% in the same period last year.

Shares of the company declined Rs 17.35, or 2.46%, to trade at Rs 688.20. The total volume of shares traded was 789,093 at the BSE (1.00 p.m., Tuesday).